Products for Research Use Only
RegisterLogin

Atoltivimab

CAT: 0804-HY-P99343-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99343-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA) -approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection[1].
CAS Number
2135632-29-8
Product Name Alternative
REGN3470
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/atoltivimab.html
Purity
98.66
Solubility
10 mM in DMSO
Smiles
[Atoltivimab]
Molecular Weight
(145.1 kDa)
References & Citations
[1]Saxena D, et al. Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus. Drugs Today (Barc) . 2021 Aug;57 (8) :483-490.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
EBOV

Alternative Products

CatalogName
T76848-01Atoltivimab
GTR18337930-01Atoltivimab Antibody
MBS1564068-01Research Grade Atoltivimab
KBI1161KRIBIOLISA™ Atoltivimab ELISA
047960EBOV (Atoltivimab) discontinued
E55B0753Atoltivimab (Reference antibody)
F1037-5Anti-EBOV Antibody (Atoltivimab)
ICH5362-1mgAtoltivimab Biosimilar - Research Grade
GTR18315610EBOV Reference Antibody (Atoltivimab)
GTR18697428-01Atoltivimab Human Monoclonal Antibody

Popular Products